Sofia D. Merajver
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Epidemiology, Public Health, Molecular BiologyGoogle:
"Sofia Merajver"Cross-listing: PHTree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Laws A, Leonard S, Hershey E, et al. (2024) ASO Visual Abstract: Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of Surgical Oncology |
Laws A, Leonard S, Hershey E, et al. (2024) Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of Surgical Oncology |
Liu Y, Joy ST, Henley MJ, et al. (2023) Inhibition of CREB Binding and Function with a Dual-Targeting Ligand. Biochemistry |
Daly MB, Pal T, Maxwell KN, et al. (2023) NCCN GuidelinesĀ® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 1000-1010 |
Fleege NMG, Pierce-Gjeldum D, Swartz LK, et al. (2022) IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases. Jco Oncology Practice. OP2200291 |
Abraham HG, Ulintz PJ, Goo L, et al. (2021) RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers. Frontiers in Oncology. 11: 712041 |
Lloyd JP, Soellner MB, Merajver SD, et al. (2021) Impact of between-tissue differences on pan-cancer predictions of drug sensitivity. Plos Computational Biology. 17: e1008720 |
Jiagge EM, Ulintz PJ, Wong S, et al. (2021) Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry. Breast Cancer Research and Treatment |
Daly MB, Pal T, Berry MP, et al. (2021) Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 19: 77-102 |
Bhatia S, Palomares MR, Hageman L, et al. (2020) A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at risk for Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |